Home / Healthcare / Medical Device / C-arms Market
C-arms Market Size, Share & COVID-19 Impact Analysis, By Type (Fixed and Mobile), By Application (Orthopedics and Trauma, Cardiology, Neurology, Gastroenterology, Oncology, and Others), By Detector (Flat Panel Detectors and Image Intensifier), By End-user (Hospitals, Diagnostic Centers, Specialty Clinics, and Others), and Regional Forecast, 2022-2029Report Format: PDF | Published Date: Feb, 2023 | Report ID: FBI100993 | Status : Published
The global C-arms market size was valued at USD 1.79 billion in 2021. The market is projected to grow from USD 1.87 billion in 2022 to USD 2.53 billion by 2029, exhibiting a CAGR of 4.4% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with C-arms experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. Based on our analysis, the global market exhibited a decline of -1.6% in 2020 as compared to 2019.
There is a significant shift of patients giving preference for undergoing minimally invasive procedures as compared to traditional surgeries due to reduced operation time, faster recovery period, and cost-effective outpatient care. Also, rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is increasing each year, thereby growing the need and demand for C-arms in the market.
- For instance, according to the data published by the American Society of Anesthesiologists (ASA) in 2020, nearly 50.0 million outpatient surgeries are performed in the U.S. each year.
- According to the statistics published by the Centers for Disease Control and Prevention (CDC) in July 2022, about 805,000 people in the U.S. have a heart attack every year, among which 605,000 have it for the first time.
The availability of innovative and new technological devices, which improve productivity by reducing operational time, fuels the demand for imaging systems in the market. Additionally, the focus of the key players on developing and launching new products in the market is set to strengthen their position in the market.
- For example, in November 2021, FUJIFILM Corporation launched Persona CS, a compact mobile C-arm, which provides enhanced image guidance during surgeries and emergency procedures. This launch aided the company in the expansion of its product portfolio and strengthened the company’s position in the market.
Therefore, rising prevalence of chronic diseases and the introduction of products in the market to improve the operational efficiency of hospitals and clinics are further fueling the growth of the market during the forecast period.
Decline in the Number of Surgical Procedures Led to a Decrease in the Sales of C-arms
The emergence of COVID-19 impeded the demand for C-arms due to decreased patient visits to hospitals and reduced surgical procedures. Key players in the market recorded a significant decline in revenues due to the COVID-19 pandemic. The reallocation of healthcare resources, declining number of patient visits to emergency care and outpatient settings, disruptions in supply chains, and other major parameters impacted the sales of these systems in the market.
The market players witnessed a significant decline in revenue generated during 2020. For instance, the diagnosis and treatment segment of Koninklijke Philips N.V. generated a revenue of USD 9,732.1 million in 2020 and witnessed a decline of 3.7% as compared to USD 10,101.2 million in 2019.
However, during Q3-Q4 of the year 2020, the number of patient visits to the hospital started increasing as travel restrictions imposed by many countries were relaxed. In 2021, the number of patient visits began returning to normal, owing to higher vaccination coverage among the general population, implementation of strong guidelines and COVID-19 protocols in public places, dismissal of restrictions for travel, and others. This led to an increase in demand for medical imaging devices in 2021. For instance, the diagnosis and treatment segment of Koninklijke Philips N.V. generated a revenue of USD 10,279.8 million in 2021 and witnessed a growth of 5.6% as compared to USD 9,732.1 million in 2020. Therefore, the resumption of services positively impacted the demand for these systems in 2021.
Incorporation of Artificial Intelligence in Radiology to Propel Growth Opportunities
New technologies and advancements in image recognition with deep learning algorithms aid healthcare professionals in exceeding task-specific applications. Artificial Intelligence (AI) has been a valuable tool in many hospital applications. AI technology can examine medical imaging solutions to recognize the most effective solution for severe abnormalities across the body.
- For instance, in December 2021, researchers from Boston University developed an AI algorithm that can swiftly and automatically identify positive x-rays for fractures; this system allows radiologists to focus on viewing x-rays with favorable fractures. This system improved operational efficiency by decreasing the time taken by the patients to receive their results.
Also, the generation of AI-powered imaging devices significantly improves the patient’s diagnosis and imaging quality. Adopting this new technology brings new opportunities that can give a detailed view of the image with less dosage of radiation per image.
- For instance, in April 2022, Omega Medical Imaging, LLC launched Soteria.AI, a new modality specially designed for cardiology labs. This new product reduces radiation dose by 84.0% and provides high-quality images.
Thus, the incorporation of artificial AI in the radiology of medical devices aids in improving operational efficiency and patient outcomes, contributing to the overall surge in demand for these devices.
Rising Prevalence of Chronic Diseases and the Preferential Shift of Patients for Minimal Invasive Procedures to Propel Market Growth
Lack of physical activities, poor diet routines, and consumption of alcohol have led to an increase in the prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases.
- For instance, according to the statistics published by the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), in 2022, around six out of ten U.S. adults are suffering from at least one chronic disease.
- According to the statistics published in the U.K. Factsheet in August 2022, 7.6 million people are living with a heart disease or circulatory disease in the country. Also, 2.3 million people in the U.K. live with Coronary Heart Disease (CHD), among which around 1.5 million are men and 830,000 are women.
This rising chronic diseases prevalence has contributed to the increase in the number of surgical procedures conducted by healthcare professionals. They have observed a preferential shift of patients toward minimally invasive procedures compared to traditional surgeries. The factors such as reduced operation time and cost-effective outpatient care are the reason for this shift.
- For instance, according to a press release by Medtronic in September 2021, more than 450,000 spinal fusion procedures and 200,000 lumbar fusion procedures are performed in the U.S. each year to improve stability, correct spine deformities, and for the treatment of a condition such as degenerative disc disease.
These factors mentioned above, along with the increase in research and development investments and new product launches by key players, are driving the market growth and contributing to the increase in demand for these systems.
Refurbished Equipment Limits the Demand for New Shipments and Restricts the Growth of the Market
Advancements in terms of functionality, design, and the constant focus of market players in introducing product offerings have resulted in an increase in the cost of the system.
Various small and mid-sized healthcare infrastructure facilities prefer spending less on equipment purchases due to the limited use of these products on a regular basis. Due to this reason, they prefer buying refurbished systems, which has limited the adoption rate of new imaging product units, contributing to increased demand for refurbished products.
- For instance, according to the news published by Block Imaging, Inc., in January 2022, the new ELITE CFD and the CIOS ALPHA will cost over USD 200,000 from the manufacturer. In contrast, the cost for both refurbished systems ranges around USD 70,000.
Also, some companies are offering systems based on a subscription plan, which hampered the growth and demand for new systems. For instance, in September 2022, Turner Imaging Systems collaborated with Med One Group and launched a subscription plan called “pay as you go.” In this, customers can obtain a 16-lb SMART-C mini C-arm for a nominal monthly charge, with a minimum commitment of 12 months.
Thus, these factors have played a pivotal role in limiting the demand for new systems in the market and are restraining the market’s growth.
By Type Analysis
Increase in Collaboration among Key Players and Launch of New Products Aided Growth for the Mobile Segment
Based on type, the market is classified into fixed and mobile.
The mobile segment dominated the market in 2021. The increase in collaboration of key players with technology-based companies to bring technically advanced imaging systems in the market and rising demand for portable systems from the healthcare settings globally are driving the growth of the segment.
- For instance, in January 2022, Koninklijke Philips N.V. collaborated with Cydar, a U.K.-based company that specializes in providing cloud-based procedures maps software. The collaboration aims to integrate cloud-based AI and 3D mapping into its mobile C-arm system series – Zenition, which will assist healthcare professionals in conducting real-time surgeries.
On the other hand, the fixed segment is expected to grow at an optimal CAGR during the forecast period. The approval of certain cardiovascular procedures from the Centers for Medicare and Medicaid Services (CMS) is contributing to the growth of the segment.
- For instance, according to a press released by GE Healthcare in April 2022, the Centers for Medicare and Medicaid Services (CMS) approved for payment of certain cardiovascular procedures in 2020, which led to the frequent use of fixed C-arms in Ambulatory Surgical Centers (ASCs) and Office-based Labs (OBLs) for cardiac and peripheral vascular procedures.
By Application Analysis
Rising Prevalence of Cardiovascular Diseases aided in the Segment Growth
Based on application, the market has been segmented into orthopedics and trauma, cardiology, neurology, gastroenterology, oncology, and others.
The cardiology segment captured the largest market share in 2021. The increasing number of cardiovascular patients suffering from coronary heart disease is increasing demand for C-arms.
- For instance, according to the statistics published by the Centers for Disease Control and Prevention (CDC) in 2020, the prevalence of coronary heart disease in the U.S. adults rose by 4.6% of the total population.
On the other hand, the orthopedics and trauma segment is expected to grow at the highest CAGR during the forecast period. The emphasis of key players on receiving approvals from the regulatory authorities for introducing new products to the market contributes to the segment's growth during 2022-2029.
- For instance, in March 2021, GE Healthcare received approval from the U.S. FDA for its OEC 3D, a new surgical imaging system capable of conducting 3-D and 2-D imaging. This system has set specific standards for intraoperative 3D imaging and offers precise images for spine and orthopedic procedures.
The oncology segment is expected to grow at an optimal growth rate during the forecast period. Strategic collaborations among hospitals and manufacturing players with diversifying imaging technologies contribute to the segment's growth.
- For instance, in April 2022, Siemens Healthcare GmbH collaborated with Oulu University Hospital in Finland to expand and modernize its radiology department. The common goal of the collaboration is to ensure high-quality care throughout the region, with improved clinical processes.
By Detector Analysis
New Flat Panel Detectors Aided Clinicians and Surgeons with Simplification of their Medical Procedures
Based on detector, the market is classified into flat panel detectors and image intensifier.
Flat panel detectors segment captured the largest market share in 2021, owing to the launch of new flat panel detectors with recent technological advancements in imaging technologies, which eases the procedures for clinicians and surgeons.
- For instance, in July 2022, Ziehm Imaging launched IGZO1 flat-panel detector for intraoperative imaging. This technology used in the detector is Indium Gallium Zinc Oxide (IGZO)1 technology providing improved image quality while keeping dose levels at a minimum.
On the other hand, the image intensifier segment is expected to grow during 2022-2029. The segment’s growth is attributed to the launch of advanced imaging systems with high-quality image intensifiers that provide surgeons with detailed anatomical images during surgeries.
- For example, in February 2019, Koninklijke Philips N.V. launched Philips Zenition, a new mobile imaging platform in the U.S. The product offers two different detectors and image intensifier options and can subscribe to Philips' Technology Maximizer program, ensuring the systems remain updated.
Therefore, the introduction of advancements to the current products and launching new advanced products to improve the operational efficiency of the procedures are further fueling the segment growth during the forecast period.
By End User Analysis
Adoption of Advanced and Technologically Modified C-Arms Across Hospitals to Aid the Segment Growth
Based on end user, the market is segmented into hospitals, diagnostic centers, specialty clinics and, others. The hospitals segment held the largest market share in 2021. The rising prevalence of cardiovascular diseases and the widespread use of C-arms across radiology and surgery departments has emphasized hospitals and manufacturers to collaborate among themselves, in order to upgrade and boost their quality of care. For instance:
- In January 2022, Koninklijke Philips N.V., collaborated with University Hospital Brandenburg an der Havel, in Germany. The collaboration aimed to work on expansion of hospital’s diagnostic and therapy option and strengthen company’s presence in the market.
- In June 2021, Turner Imaging Systems collaborated with MIS Healthcare, one of the large and independent medical imaging equipment supplier throughout U.K. and Ireland. The collaboration aimed to market its SMART-C fluoroscopic mini C-arm into its diagnostic centers and other medium of channels.
Thus, the adoption of technically advanced C-arm instruments by the hospitals for the upgradation of their standard of care and the emphasis of market players on collaboration with medical equipment suppliers is augmenting the market growth during the forecast period.
Based on region, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The North America market was valued at USD 0.96 billion in 2021. The region’s dominance is due to the launch of new hybrid C-arms by manufacturing companies, which aid in improving clinicians' workflow in hospitals and ambulatory surgery centers. The introduction of this new advanced technology is fostering the market growth in the region.
- In July 2022, FUJIFILM Holdings America Corporation launched FDR Cross, a new hybrid C-arm and X-ray solution, which offers portable fluoroscopy and radiography imaging on a single platform. The introduction of this product led to the expansion of the company’s product portfolio and strengthened its position in the U.S.
Europe held the second position in the global market. The emphasis of the manufacturing companies on receiving approvals from the regulatory bodies for marketing and distribution of their products in the region is fueling the market growth in this region. For instance, in May 2021, Turner Imaging Systems received a CE mark for its ‘smart-C mini C-arm’, a portable fluoroscopy X-ray imaging device. This approval assisted the company in distributing its products in European countries and expanded its product portfolio in the market.
Asia Pacific is expected to witness the highest CAGR during the forecast period. The growth of this region is attributed to the focus of the companies on launching imaging systems for traumatic injuries and orthopedic procedures. For instance, in April 2022, Nanjing Perlove Medical Equipment Co. launched a large flat integrated c-arm – PLX119C. The PLX119C provides a broader field of view and more explicit images during an orthopedic procedure and can also measure the length and alignment of the fracture site.
On the other side, the Latin America and the Middle East regions are likely to grow at a slower pace. The rising incidence of musculoskeletal disorders and the increasing geriatric population are accelerating the C-arms market growth in the region.
- For instance, according to the data published by the Royal Society of Medicine in May 2020, it was reported that around 70,000 hip replacement procedures are performed annually in Brazil.
KEY INDUSTRY PLAYERS
Key Players on Upgrading Existing Products and Introduction of Products in the Market to Strengthen their Position
In terms of the competitive landscape, the majority of the global C-arms market share is held by GE Healthcare, Koninklijke Philips N.V., and Siemens Healthcare GmbH. These companies are the leading players in the global market. The major factors responsible for the leading position of the key companies are a wide range of product portfolios and the increasing focus on introducing advanced products to the market.
- In January 2020, Koninklijke Philips N.V. added new capabilities to the Zenition mobile C-arm platform, enabling clinicians to operate in a sterile field by diminishing the communication burden and the integration of intravascular ultrasound for peripheral vascular procedures. This new development to the product enhanced the workflow of clinicians in the operating room.
Other companies, such as Ziehm Imaging GmbH and CANON MEDICAL SYSTEMS CORPORATION, have a prominent presence in the global market. The amendment to their existing products for building improved quality products that provide high-resolution images during the procedures is expected to propel the growth of these companies.
- In November 2021, Canon Medical Systems Corporation introduced High-Definition (Hi-Def) imaging detector and made it available on its C-arm systems such as Alphenix Sky. The installation of these detectors improved the resolution for clinicians and enabled them to improve patient outcomes.
List of Key Companies Profiled:
- General Electric Company (GE Healthcare) (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Siemens Healthcare GmbH (Germany)
- CANON MEDICAL SYSTEMS CORPORATION (Japan)
- Hologic, Inc. (U.S.)
- Shimadzu Corporation (Japan)
- Ziehm Imaging GmbH (Germany)
- FUJIFILM Corporation (Japan)
- Genoray Co., Ltd. (South Korea)
KEY INDUSTRY DEVELOPMENTS:
- July 2022 – Canon Medical Systems USA Inc. acquired NXC Imaging, a medical imaging equipment distributor and service provider in Minneapolis, Minnesota in the U.S. The aim of this acquisition is to widen their sales and service in the U.S. and expand their geographic outreach in the Midwest region.
- February 2022 – Siemens Healthcare GmbH announced to invest in the manufacturing and R&D capabilities of more than 15 locations in the U.S. This investment aims to expand its diagnostics imaging and laboratory diagnostics portfolios and strengthen its geographical presence in the country.
- April 2021 – Nanjing Perlove Medical Equipment Co. collaborated with Mudanjiang Forestry Central Hospital in China. The collaboration aims to implement high-frequency mobile C-arms in the hospital diagnostic department and strengthen its technological facilities.
- January 2020 – Trivitron Healthcare launched Elite flat panel digital C-arm at the Arab Health 2020 Conference in Dubai. This new product demonstrates images with black and white resolution making the visibility of the various anatomical structures more accurate.
- September 2019 – Orthoscan, Inc. launched the Orthoscan TAU family of mini C-arms and received approval for its use in pediatric patients. The family consists of TAU 1512, TAU 1515, TAU 2020 and has a large detector for reviewing critical anatomy with exclusive dose saving feature.
The market research report provides a detailed analysis of the market. It focuses on key aspects of its type, application, and detector. Besides this, it offers insights into the market trends and highlights key industry developments, mergers, and acquisitions, technological advancements of the major players with impact of COVID-19 on the market. In addition to the above mentioned factors, the report encompasses several factors that have contributed to the market's growth in recent years.
Report Scope & Segmentation
Value (USD billion)
By Type, Application, Detector, End-user, and Region
Frequently Asked Questions
How much is the global C-arms market worth?
Fortune Business Insights says that the global market stood at USD 1.79 billion in 2021 and is projected to reach USD 2.53 billion by 2029.
What was the value of the global C-arms market in 2021?
In 2021, the market stood at USD 1.79 billion.
At what CAGR is the market projected to grow in the forecast period (2022-2029)?
Growing at a CAGR of 4.4%, the market will exhibit faster growth during the forecast period (2022-2029).
Which is the leading segment in the market?
The mobile segment is expected to be the leading segment in the market during the forecast period.
What is the key factor driving the market?
The rising prevalence of chronic diseases and the preferential shift of patients toward minimal invasive procedures will drive the market.
Who are the top players in the market?
GE Healthcare, Koninklijke Philips N.V., and Siemens Healthcare GmbH are the top players in the market.
Which region is expected to hold the highest market share in the market?
North America is expected to hold the highest market share.
- Inquiry Before Buying